Table 1 from Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non–Small Cell Lung Cancer Harboring EGFR Mutation
收藏数据链接：
官方服务：
资源简介：
Patient characteristics. Data are presented as median (range) or n (%).
创建时间：
2025-06-13
